With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

F45 Training Holdings Inc., a leading global fitness community known for innovative, high-energy group workouts, announced ...

The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for the next 12 months.Many resolutions ...

Digital technologies loom large on the list—from the growing impact of artificial intelligence to the need for tech-enabled ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

Highmark Health President and CEO David Holmberg discussed the uncertainties facing the insurance industry, including the ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...

Their top 10 list includes GLP-1 drugs, salt and sugar reduction and growing use of AI, in the lab and at home.

OpenAI CEO Sam Altman and Meta both announced $1 million donations, and Amazon and Apple CEO Tim Cook have also reportedly ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight ...